These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6248221)

  • 1. Comparative pharmacokinetics of cefoperazone and cefotaxime.
    Lode H; Kemmerich B; Koeppe P; Belmega D; Jendroschek H
    Clin Ther; 1980; 3(Spec Issue):80-8. PubMed ID: 6248221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
    Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P
    Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
    Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC
    Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study on the interstitial passage of cefuroxime, cefoxitin, cefotaxime and cefoperazone in man by the suction skin blister method.
    Frongillo RF; Galuppo L; Moretti A
    Boll Ist Sieroter Milan; 1983 Nov; 62(5):412-6. PubMed ID: 6322818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefoperazone: pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats.
    Balant L; Dayer P; Rudhardt M; Allaz AF; Fabre J
    Clin Ther; 1980; 3(Spec Issue):50-9. PubMed ID: 6446399
    [No Abstract]   [Full Text] [Related]  

  • 6. Perioperative pharmacokinetics of cefotaxime in serum and bile during continuous and intermittent infusion in liver transplant patients.
    Buijk SE; Gyssens IC; Mouton JW; Metselaar HJ; Groenland TH; Verbrugh HA; Bruining HA
    J Antimicrob Chemother; 2004 Jul; 54(1):199-205. PubMed ID: 15175266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cefoperazone--a new cephalosporin antibiotic with broader spectrum of activity].
    Jendroschek T; Belmega G; Lode H; Kemmerich B; Dzwillo G; Koeppe P; Wagner J
    Med Klin; 1981 Feb; 76(4):102-6, 70. PubMed ID: 6452567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kinetics of cefotaxime in healthy subjects (author's transl)].
    Acar JF; Guibert J; Kitzis MD
    Nouv Presse Med; 1981 Feb; 10(8):559-63. PubMed ID: 6259593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure].
    Belaieff J; Cochet B; Allaz AF; Rudhardt M; Balant L; Fabre J
    Schweiz Med Wochenschr; 1981 Apr; 111(14):502-8. PubMed ID: 6453423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
    Weber W; Harnisch L; Zimmer M; Rokitta C; Mendes P
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):560-4. PubMed ID: 8574507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics and metabolism of the cephalosporins].
    Graninger W
    Wien Klin Wochenschr Suppl; 1983; 142():11-5. PubMed ID: 6580781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefoperazone in healthy volunteers.
    Saudek F; Morávek J; Modr Z
    Czech Med; 1986; 9(3):162-5. PubMed ID: 3095076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic study of a cephalosporin: cefoperazone in patients with a Kehr drain].
    Farquet C; Marti MC; Balant L; Cochet B; Rudhardt M; Fabre J; Rohner A
    Schweiz Med Wochenschr; 1982 Jan; 112(4):123-9. PubMed ID: 6461067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusibility of the newer cephalosporins into human interstitial fluids.
    Tan JS; Salstrom SJ; File TM
    Am J Med; 1984 Oct; 77(4C):33-6. PubMed ID: 6093516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency.
    Bolton WK; Scheld WM; Spyker DA; Sande MA
    Antimicrob Agents Chemother; 1981 May; 19(5):821-5. PubMed ID: 6457558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfiram-like reaction associated with a parenteral cephalosporin.
    Foster TS; Raehl CL; Wilson HD
    Am J Hosp Pharm; 1980 Jun; 37(6):858-9. PubMed ID: 6446854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose pharmacokinetics of cefoperazone following intravenous administration.
    Craig WA
    Clin Ther; 1980; 3(Spec Issue):46-9. PubMed ID: 6446398
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum and urine concentrations of cefoperazone in severe chronic renal failure.
    Bailey RR; Peddie B; Blake E
    Drugs; 1981; 22 Suppl 1():46-51. PubMed ID: 6456891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefoperazone: a review.
    Craig WA; Gerber AU
    Drugs; 1981; 22 Suppl 1():35-45. PubMed ID: 6456890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.